Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The potential reclassification of cannabis by the DEA, removing it from the schedule-1 drugs list, could significantly impact both medical research and patient access. By allowing the FDA to thoroughly study cannabis for its medical applications, we could see more evidence-based treatments emerge. Additionally, this change could pave the way for insurance companies to include medical cannabis in their coverage, potentially reducing costs for patients through co-pay systems akin to those used for traditional prescription medications. This shift could make medical cannabis more accessible and affordable for those who need it.
The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what is used for prescription medications at pharmacies.
The DEA could remove cannabis from the list of schedule-1 drugs so that the FDA can study it for medical purposes and insurance companies can help patients by reducing the overall cost of medical cannabis through the use of a co-pay similar to picking up a prescription at a pharmacy.
The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what is used for prescription medications at pharmacies.
$MSOS $MRMD
If the DEA reclassifies cannabis and takes it off the schedule-1 drugs list, the FDA could study it for medical uses. This would also allow insurance companies to help patients reduce the cost of medical cannabis, using a co-pay system like the one for pharmacy prescriptions.
$MSOS $MRMD
The potential reclassification of cannabis by the DEA, removing it from the schedule-1 drugs list, could significantly impact both medical research and patient access. By allowing the FDA to thoroughly study cannabis for its medical applications, we could see more evidence-based treatments emerge. Additionally, this change could pave the way for insurance companies to include medical cannabis in their coverage, potentially reducing costs for patients through co-pay systems akin to those used for traditional prescription medications. This shift could make medical cannabis more accessible and affordable for those who need it.
$MSOS $MRMD
$MRMD The DEA could remove cannabis from the list of schedule-1 drugs so that the FDA can study it for medical purposes and insurance companies can help patients by reducing the overall cost of medical cannabis through the use of a co-pay similar to picking up a prescription at a pharmacy.
Medical Cannabis Ice-cream:
https://www.bettyseddies.com/categories/ice-cream
$MRMD: The DEA could remove cannabis from the list of schedule-1 drugs so that the FDA can study it for medical purposes and insurance companies can help patients by reducing the overall cost of medical cannabis through the use of a co-pay similar to picking up a prescription at a pharmacy.
$MRMD - Cannabis Icecream
https://www.bettyseddies.com/categories/ice-cream
https://www.youtube.com/shorts/KsYYrvMNybc
$MRMD - Cannabis Icecream
https://www.bettyseddies.com/categories/ice-cream
https://www.youtube.com/shorts/KsYYrvMNybc
$INTC $MRMD $GOOGL $V $MA $MSFT
$UNP $UPS $VRSK $WWD
$PG $MRMD $SYY $WBA $WMT
$PNC $MRMD $PGR $PLD $PSA
$NKE $MRMD $ORLY $ROST $SBUX
Bearish Implications:
Economic Outlook: The uncertainty in building reports and the flat retail sales growth points to potential weaknesses in the economy. This can result in cautious investor behavior and potential declines in market indices.
Market Sentiment: The unknown actual data for building reports adds to market uncertainty, potentially increasing volatility. The flat retail sales growth does not significantly boost sentiment.
Policy Implications: Policymakers might consider economic stimulus measures to address potential weaknesses and uncertainty in the construction sector and to boost consumer confidence.
https://tradingeconomics.com/calendar
"Yellow 6" caused adrenal tumors in animals, though that is disputed by industry and the FDA. It may be contaminated with cancer-causing chemicals and occasionally causes severe hypersensitivity reactions. Minute Maid lemonade by Coca-Cola in the US contains the artificial food dye Yellow 5.
Reduced purchasing power of a currency generally leads to a bearish outlook for the stock market.
Building Reports: https://tradingeconomics.com/calendar
Even if the Federal Reserve raises interest rates, other factors can keep prices high.
For example:
- Supply Chain Issues: Ongoing supply chain disruptions can limit the supply of goods, driving up prices.
- Labor Market: Tight labor markets can lead to higher wages, which businesses may pass on to consumers through higher prices.
- Energy Prices: Volatile energy prices can directly impact the cost of goods and services.
- Consumer Demand: If consumer demand remains strong despite higher interest rates, prices may not fall significantly.
#CPI #BEAR #USD
Politics may restrict the use of self-driving vehicles.
Samsung has better phones.
HP has better computers.
META has better virtual reality.
$DUK
$DUK
$DUK
There is a detachment between employees and upper management in nearly every major company.
Home Depot may face lawsuits regarding "back injuries".
Costco might face lawsuit relating to gender discrimination.
Headsets have been causing headaches because the screen is too close to the human's eyes.
Employee's use plastic bottles as urinals in the delivery vans.
The I.T. department should fix the errors related to the search terms during the checkout process. It took a cashier over 10 mins to find "gray cement brick" in their system because it had over 4,000 results. That one store doesn't carry that many items related to that product. There is no reason to have a search related to the entire company when I just want to know what is available in the store that I am currently shopping.
Building Reports: https://tradingeconomics.com/calendar
CPI and FOMC: https://tradingeconomics.com/calendar
560 next week!
Amazon may face "lawsuits" regarding bathroom breaks.
$300 this week.